EBITDA Archives - Page 2 of 4 - Express Pharma

Sun Pharma posts Q3FY20 gross sales at Rs 8,039 crores

Strides posts consolidated revenue at ₹7,353 m in Q3FY20

Biocon sees revenue growth of 14 per cent to Rs 1,784 crores in Q3FY20

Syngene reports 11 per cent revenue growth in Q3 to Rs 539 crores

Lonza seeks drug industry veteran as CEO to sharpen pharma focus

UFlex closes Q2 of FY19-20 with EBITDA of 279 cr

Ajanta Pharma’s total comprehensive income dips by 23% in Q1 FY 2018

DRL posts Q2 FY17 and H1FY17 results

Ajanta Pharma posts Q4 and FY 2016 results

Syngene delivers sustained growth in Q4 FY16